Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
Zai Laboratory (ZLAB:Nasdaq) landed the Hong Kong Stock Exchange today, with an open price of HKD 613.5, 9.16% up from the issuance price of HKD 562. The second time the biotechnology hit a public market after the 2017 IPO on the Nasdaq market.
At the startup phase, the company received the investment from Sequoia, Qiming Ventures Taifu Captial. After two years, three investors continued to engage in the company's Series B fundraising of USD 106.2 million, together with Shangcheng Capital. As of July 1st, 2020, Qiming Ventures was the institutional equity holder with the most shares – 12.25% and the founder, Dr. Du Ying 4% shares.
The IPO bankroll, as much as HKD 6 billion, will help ease the Zai Lab's liquidity stress, expand the global business network and collaboration.
Source: VCbeat
Original: Check out
Briefing updated 5 hours ago
· Healthcare
Improving service quality and enabling industrial innovation!
Briefing Nov 20, 2020 08:14 PM
· Healthcare
Pfizer submitted to FDA for authorization of emergency use of new crown vaccine
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Nov 20, 2020 11:57 AM
· Healthcare
The new crown vaccine developed by academician Chen Wei and kangxinuo biology can be stable for a long time from 2 to 8 degrees
Briefing Nov 19, 2020 10:22 AM
· Healthcare
Geli pharmaceutical: asc40 (tvb-2640) China has completed phase II NASH patients
Research
Healthcare, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Consumer Staples, Industrials, FinancialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Apr 26, 2020 03:17 PM
Apr 19, 2020 06:36 PM
Briefing Nov 19, 2020 09:57 AM
· Healthcare
Heyuan biological has completed a new round of financing of 450 million yuan, and car-t products with independent intellectual property rights have entered clinical phase II
Briefing Nov 19, 2020 09:47 AM
· Healthcare
Lukang Pharmaceutical holding subsidiary ambroxol hydrochloride injection obtained drug registration certificate
Briefing Nov 19, 2020 09:33 AM
· Healthcare
Baiji Shenzhou: midterm analysis of the global phase III clinical trial for the treatment of non-small cell lung cancer reached the main end point
Briefing Nov 17, 2020 08:04 PM
· Healthcare
Plan to raise $4 billion! Jingdong health runs IPO
Healthcare
WIM Presents Next 50 in Global Tech: Healthcare
In 2020, as COVID-19 spread around the world, people began to pay more attention to the healthcare industry. The crisis of the pandemic has led directly to significant changes in the healthcare industry across the globe.
Oct 29, 2020 11:00 AM
Briefing Nov 11, 2020 10:42 AM
· Healthcare
Drug Innovator Asieris Nabs CNY 700 Million Series D
Briefing Nov 03, 2020 12:06 PM
· Healthcare
HaoYuan Chemexpress Files for IPO on the Star Market
Briefing Oct 16, 2020 04:24 PM
· Healthcare
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Healthcare, Industrials, Communication · Analysis
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
Briefing Sep 28, 2020 12:12 PM
· Healthcare
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Briefing Sep 28, 2020 10:49 AM
· Healthcare
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
Briefing Sep 23, 2020 11:37 AM
· Healthcare
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Briefing Sep 23, 2020 11:11 AM
· Healthcare
Tongshu Gene Closes Series B of Multi-Hundreds Millions
See more
Read next
In depth
Technology
Pains Behind Xiaomi's Record Highs in 3Q 2020: A Long Way to Greatness
Nov 29, 2020 07:38 PM
In depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.